| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.996 | 0 | 0.996 | Vasodilator | 0.996 0 DBMET02594 0.996 0 DBMET02598 0.996 0 DBMET02595 0.996 0 DBMET02596 0.996 0 DBMET02597 | ||
| 0.993 | 0 | 0.993 | Nitric oxide donor | 0.993 0 DBMET02594 0.993 0 DBMET02598 0.993 0 DBMET02595 0.993 0 DBMET02596 0.993 0 DBMET02597 | ||
| 0.981 | 0.003 | 0.981 | Analgesic | 0.981 0.003 DBMET02594 0.981 0.003 DBMET02598 0.981 0.003 DBMET02595 0.981 0.003 DBMET02596 0.981 0.003 DBMET02597 | ||
| 0.978 | 0.002 | 0.978 | Cyclooxygenase inhibitor | 0.978 0.002 DBMET02594 0.978 0.002 DBMET02598 0.978 0.002 DBMET02595 0.978 0.002 DBMET02596 0.978 0.002 DBMET02597 | ||
| 0.976 | 0.002 | 0.976 | Cyclooxygenase 2 inhibitor | 0.976 0.002 DBMET02594 0.976 0.002 DBMET02598 0.976 0.002 DBMET02595 0.976 0.002 DBMET02596 0.976 0.002 DBMET02597 | ||
| 0.974 | 0.002 | 0.974 | Cyclooxygenase 1 inhibitor | 0.974 0.002 DBMET02594 0.974 0.002 DBMET02598 0.974 0.002 DBMET02595 0.974 0.002 DBMET02596 0.974 0.002 DBMET02597 | ||
| 0.966 | 0.003 | 0.966 | Cardiotonic | 0.966 0.003 DBMET02594 0.966 0.003 DBMET02598 0.966 0.003 DBMET02595 0.966 0.003 DBMET02596 0.966 0.003 DBMET02597 | ||
| 0.945 | 0.003 | 0.945 | Platelet aggregation inhibitor | 0.945 0.003 DBMET02594 0.945 0.003 DBMET02598 0.945 0.003 DBMET02595 0.945 0.003 DBMET02596 0.945 0.003 DBMET02597 | ||
| 0.94 | 0.003 | 0.94 | Platelet antagonist | 0.94 0.003 DBMET02594 0.94 0.003 DBMET02598 0.94 0.003 DBMET02595 0.94 0.003 DBMET02596 0.94 0.003 DBMET02597 | ||
| 0.938 | 0.005 | 0.938 | Antiinflammatory | 0.938 0.005 DBMET02594 0.938 0.005 DBMET02598 0.938 0.005 DBMET02595 0.938 0.005 DBMET02596 0.938 0.005 DBMET02597 | ||
| 0.909 | 0.003 | 0.909 | Adrenaline antagonist | 0.909 0.003 DBMET02594 0.909 0.003 DBMET02598 0.909 0.003 DBMET02595 0.909 0.003 DBMET02596 0.909 0.003 DBMET02597 | ||
| 0.909 | 0.003 | 0.909 | Antiadrenergic | 0.909 0.003 DBMET02594 0.909 0.003 DBMET02598 0.909 0.003 DBMET02595 0.909 0.003 DBMET02596 0.909 0.003 DBMET02597 | ||
| 0.855 | 0.005 | 0.855 | Cyclophilin D inhibitor | 0.855 0.005 DBMET02594 0.855 0.005 DBMET02598 0.855 0.005 DBMET02595 0.855 0.005 DBMET02596 0.855 0.005 DBMET02597 | ||
| 0.844 | 0.003 | 0.844 | Vasodilator, peripheral | 0.844 0.003 DBMET02594 0.844 0.003 DBMET02598 0.844 0.003 DBMET02595 0.844 0.003 DBMET02596 0.844 0.003 DBMET02597 | ||
| 0.831 | 0.003 | 0.831 | Vasodilator, coronary | 0.831 0.003 DBMET02594 0.831 0.003 DBMET02598 0.831 0.003 DBMET02595 0.831 0.003 DBMET02596 0.831 0.003 DBMET02597 | ||
| 0.787 | 0.001 | 0.787 | Guanylate cyclase stimulant | 0.787 0.001 DBMET02594 0.787 0.001 DBMET02598 0.787 0.001 DBMET02595 0.787 0.001 DBMET02596 0.787 0.001 DBMET02597 | ||
| 0.779 | 0.004 | 0.779 | Spasmolytic | 0.779 0.004 DBMET02594 0.779 0.004 DBMET02598 0.779 0.004 DBMET02595 0.779 0.004 DBMET02596 0.779 0.004 DBMET02597 | ||
| 0.725 | 0.003 | 0.725 | Anesthetic general | 0.725 0.003 DBMET02594 0.725 0.003 DBMET02598 0.725 0.003 DBMET02595 0.725 0.003 DBMET02596 0.725 0.003 DBMET02597 | ||
| 0.69 | 0.005 | 0.69 | Hypoglycemic | 0.69 0.005 DBMET02594 0.69 0.005 DBMET02598 0.69 0.005 DBMET02595 0.69 0.005 DBMET02596 0.69 0.005 DBMET02597 | ||
| 0.661 | 0.004 | 0.661 | Platelet adhesion inhibitor | 0.661 0.004 DBMET02594 0.661 0.004 DBMET02598 0.661 0.004 DBMET02595 0.661 0.004 DBMET02596 0.661 0.004 DBMET02597 | ||
| 0.602 | 0.011 | 0.602 | Antioxidant | 0.602 0.011 DBMET02594 0.602 0.011 DBMET02598 0.602 0.011 DBMET02595 0.602 0.011 DBMET02596 0.602 0.011 DBMET02597 | ||
| 0.561 | 0.009 | 0.561 | DNA synthesis inhibitor | 0.561 0.009 DBMET02594 0.561 0.009 DBMET02598 0.561 0.009 DBMET02595 0.561 0.009 DBMET02596 0.561 0.009 DBMET02597 | ||
| 0.588 | 0.052 | 0.588 | Apoptosis agonist | 0.588 0.052 DBMET02594 0.588 0.052 DBMET02598 0.588 0.052 DBMET02595 0.588 0.052 DBMET02596 0.588 0.052 DBMET02597 | ||
| 0.533 | 0.01 | 0.533 | Angiogenesis stimulant | 0.533 0.01 DBMET02594 0.533 0.01 DBMET02598 0.533 0.01 DBMET02595 0.533 0.01 DBMET02596 0.533 0.01 DBMET02597 | ||
| 0.518 | 0.03 | 0.518 | Cholesterol antagonist | 0.518 0.03 DBMET02594 0.518 0.03 DBMET02598 0.518 0.03 DBMET02595 0.518 0.03 DBMET02596 0.518 0.03 DBMET02597 | ||
| 0.477 | 0.007 | 0.477 | Calcium channel activator | 0.477 0.007 DBMET02594 0.477 0.007 DBMET02598 0.477 0.007 DBMET02595 0.477 0.007 DBMET02596 0.477 0.007 DBMET02597 | ||
| 0.457 | 0.006 | 0.457 | Alpha-N-acetylglucosaminidase inhibitor | 0.457 0.006 DBMET02594 0.457 0.006 DBMET02598 0.457 0.006 DBMET02595 0.457 0.006 DBMET02596 0.457 0.006 DBMET02597 | ||
| 0.41 | 0.057 | 0.41 | GABA C receptor rho-3 antagonist | 0.41 0.057 DBMET02594 0.41 0.057 DBMET02598 0.41 0.057 DBMET02595 0.41 0.057 DBMET02596 0.41 0.057 DBMET02597 | ||
| 0.347 | 0.008 | 0.347 | Butyrylcholinesterase inhibitor | 0.347 0.008 DBMET02594 0.347 0.008 DBMET02598 0.347 0.008 DBMET02595 0.347 0.008 DBMET02596 0.347 0.008 DBMET02597 | ||
| 0.367 | 0.035 | 0.367 | Free radical scavenger | 0.367 0.035 DBMET02594 0.367 0.035 DBMET02598 0.367 0.035 DBMET02595 0.367 0.035 DBMET02596 0.367 0.035 DBMET02597 | ||
| 0.34 | 0.009 | 0.34 | Insulin secretagoues | 0.34 0.009 DBMET02594 0.34 0.009 DBMET02598 0.34 0.009 DBMET02595 0.34 0.009 DBMET02596 0.34 0.009 DBMET02597 | ||
| 0.317 | 0.025 | 0.317 | Non-steroidal antiinflammatory agent | 0.317 0.025 DBMET02594 0.317 0.025 DBMET02598 0.317 0.025 DBMET02595 0.317 0.025 DBMET02596 0.317 0.025 DBMET02597 | ||
| 0.299 | 0.023 | 0.299 | Diuretic | 0.299 0.023 DBMET02594 0.299 0.023 DBMET02598 0.299 0.023 DBMET02595 0.299 0.023 DBMET02596 0.299 0.023 DBMET02597 | ||
| 0.28 | 0.005 | 0.28 | Phosphodiesterase 5A inhibitor | 0.28 0.005 DBMET02594 0.28 0.005 DBMET02598 0.28 0.005 DBMET02595 0.28 0.005 DBMET02596 0.28 0.005 DBMET02597 | ||
| 0.278 | 0.006 | 0.278 | Calcium antagonist | 0.278 0.006 DBMET02594 0.278 0.006 DBMET02598 0.278 0.006 DBMET02595 0.278 0.006 DBMET02596 0.278 0.006 DBMET02597 | ||
| 0.294 | 0.031 | 0.294 | Hepatoprotectant | 0.294 0.031 DBMET02594 0.294 0.031 DBMET02598 0.294 0.031 DBMET02595 0.294 0.031 DBMET02596 0.294 0.031 DBMET02597 | ||
| 0.261 | 0.005 | 0.261 | Phosphodiesterase V inhibitor | 0.261 0.005 DBMET02594 0.261 0.005 DBMET02598 0.261 0.005 DBMET02595 0.261 0.005 DBMET02596 0.261 0.005 DBMET02597 | ||
| 0.25 | 0.006 | 0.25 | CF transmembrane conductance regulator agonist | 0.25 0.006 DBMET02594 0.25 0.006 DBMET02598 0.25 0.006 DBMET02595 0.25 0.006 DBMET02596 0.25 0.006 DBMET02597 | ||
| 0.369 | 0.13 | 0.369 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.369 0.13 DBMET02594 0.369 0.13 DBMET02598 0.369 0.13 DBMET02595 0.369 0.13 DBMET02596 0.369 0.13 DBMET02597 | ||
| 0.24 | 0.01 | 0.24 | Cyclooxygenase 3 inhibitor | 0.24 0.01 DBMET02594 0.24 0.01 DBMET02598 0.24 0.01 DBMET02595 0.24 0.01 DBMET02596 0.24 0.01 DBMET02597 | ||
| 0.259 | 0.03 | 0.259 | Insulin sensitizer | 0.259 0.03 DBMET02594 0.259 0.03 DBMET02598 0.259 0.03 DBMET02595 0.259 0.03 DBMET02596 0.259 0.03 DBMET02597 | ||
| 0.239 | 0.014 | 0.239 | UDP-glucose 4-epimerase inhibitor | 0.239 0.014 DBMET02594 0.239 0.014 DBMET02598 0.239 0.014 DBMET02595 0.239 0.014 DBMET02596 0.239 0.014 DBMET02597 | ||
| 0.252 | 0.031 | 0.252 | Nitric-oxide synthase stimulant | 0.252 0.031 DBMET02594 0.252 0.031 DBMET02598 0.252 0.031 DBMET02595 0.252 0.031 DBMET02596 0.252 0.031 DBMET02597 | ||
| 0.221 | 0.004 | 0.221 | Beta adrenoreceptor antagonist | 0.221 0.004 DBMET02594 0.221 0.004 DBMET02598 0.221 0.004 DBMET02595 0.221 0.004 DBMET02596 0.221 0.004 DBMET02597 | ||
| 0.221 | 0.009 | 0.221 | Triose-phosphate isomerase inhibitor | 0.221 0.009 DBMET02594 0.221 0.009 DBMET02598 0.221 0.009 DBMET02595 0.221 0.009 DBMET02596 0.221 0.009 DBMET02597 | ||
| 0.206 | 0.003 | 0.206 | Beta 1 adrenoreceptor antagonist | 0.206 0.003 DBMET02594 0.206 0.003 DBMET02598 0.206 0.003 DBMET02595 0.206 0.003 DBMET02596 0.206 0.003 DBMET02597 | ||
| 0.272 | 0.074 | 0.272 | Aldehyde oxidase inhibitor | 0.272 0.074 DBMET02594 0.272 0.074 DBMET02598 0.272 0.074 DBMET02595 0.272 0.074 DBMET02596 0.272 0.074 DBMET02597 | ||
| 0.219 | 0.023 | 0.219 | Calcium channel blocker | 0.219 0.023 DBMET02594 0.219 0.023 DBMET02598 0.219 0.023 DBMET02595 0.219 0.023 DBMET02596 0.219 0.023 DBMET02597 | ||
| 0.226 | 0.032 | 0.226 | Succinate dehydrogenase inhibitor | 0.226 0.032 DBMET02594 0.226 0.032 DBMET02598 0.226 0.032 DBMET02595 0.226 0.032 DBMET02596 0.226 0.032 DBMET02597 | ||
| 0.289 | 0.096 | 0.289 | Antithrombotic | 0.289 0.096 DBMET02594 0.289 0.096 DBMET02598 0.289 0.096 DBMET02595 0.289 0.096 DBMET02596 0.289 0.096 DBMET02597 | ||
| 0.189 | 0.006 | 0.189 | Calcium channel L-type blocker | 0.189 0.006 DBMET02594 0.189 0.006 DBMET02598 0.189 0.006 DBMET02595 0.189 0.006 DBMET02596 0.189 0.006 DBMET02597 | ||
| 0.216 | 0.036 | 0.216 | Lipid peroxidase inhibitor | 0.216 0.036 DBMET02594 0.216 0.036 DBMET02598 0.216 0.036 DBMET02595 0.216 0.036 DBMET02596 0.216 0.036 DBMET02597 | ||
| 0.231 | 0.051 | 0.231 | Peroxidase inhibitor | 0.231 0.051 DBMET02594 0.231 0.051 DBMET02598 0.231 0.051 DBMET02595 0.231 0.051 DBMET02596 0.231 0.051 DBMET02597 | ||
| 0.2 | 0.02 | 0.2 | GABA C receptor agonist | 0.2 0.02 DBMET02594 0.2 0.02 DBMET02598 0.2 0.02 DBMET02595 0.2 0.02 DBMET02596 0.2 0.02 DBMET02597 | ||
| 0.249 | 0.069 | 0.249 | Tyrosine 3 hydroxylase inhibitor | 0.249 0.069 DBMET02594 0.249 0.069 DBMET02598 0.249 0.069 DBMET02595 0.249 0.069 DBMET02596 0.249 0.069 DBMET02597 | ||
| 0.182 | 0.003 | 0.182 | Guanylate cyclase 1 stimulant | 0.182 0.003 DBMET02594 0.182 0.003 DBMET02598 0.182 0.003 DBMET02595 0.182 0.003 DBMET02596 0.182 0.003 DBMET02597 | ||
| 0.19 | 0.016 | 0.19 | Adenylate kinase inhibitor | 0.19 0.016 DBMET02594 0.19 0.016 DBMET02598 0.19 0.016 DBMET02595 0.19 0.016 DBMET02596 0.19 0.016 DBMET02597 | ||
| 0.33 | 0.163 | 0.33 | Caspase 9 stimulant | 0.33 0.163 DBMET02594 0.33 0.163 DBMET02598 0.33 0.163 DBMET02595 0.33 0.163 DBMET02596 0.33 0.163 DBMET02597 | ||
| 0.249 | 0.089 | 0.249 | 5 Hydroxytryptamine release stimulant | 0.249 0.089 DBMET02594 0.249 0.089 DBMET02598 0.249 0.089 DBMET02595 0.249 0.089 DBMET02596 0.249 0.089 DBMET02597 | ||
| 0.171 | 0.014 | 0.171 | Phosphofructokinase-1 inhibitor | 0.171 0.014 DBMET02594 0.171 0.014 DBMET02598 0.171 0.014 DBMET02595 0.171 0.014 DBMET02596 0.171 0.014 DBMET02597 | ||
| 0.242 | 0.089 | 0.242 | 5 Hydroxytryptamine uptake stimulant | 0.242 0.089 DBMET02594 0.242 0.089 DBMET02598 0.242 0.089 DBMET02595 0.242 0.089 DBMET02596 0.242 0.089 DBMET02597 | ||
| 0.16 | 0.01 | 0.16 | Carbamoyl phosphate synthetase inhibitor | 0.16 0.01 DBMET02594 0.16 0.01 DBMET02598 0.16 0.01 DBMET02595 0.16 0.01 DBMET02596 0.16 0.01 DBMET02597 | ||
| 0.157 | 0.009 | 0.157 | Alcohol oxidase inhibitor | 0.157 0.009 DBMET02594 0.157 0.009 DBMET02598 0.157 0.009 DBMET02595 0.157 0.009 DBMET02596 0.157 0.009 DBMET02597 | ||
| 0.305 | 0.159 | 0.305 | 5 Hydroxytryptamine release inhibitor | 0.305 0.159 DBMET02594 0.305 0.159 DBMET02598 0.305 0.159 DBMET02595 0.305 0.159 DBMET02596 0.305 0.159 DBMET02597 | ||
| 0.2 | 0.062 | 0.2 | 5 Hydroxytryptamine 3E antagonist | 0.2 0.062 DBMET02594 0.2 0.062 DBMET02598 0.2 0.062 DBMET02595 0.2 0.062 DBMET02596 0.2 0.062 DBMET02597 | ||
| 0.16 | 0.024 | 0.16 | Ca2+-transporting ATPase inhibitor | 0.16 0.024 DBMET02594 0.16 0.024 DBMET02598 0.16 0.024 DBMET02595 0.16 0.024 DBMET02596 0.16 0.024 DBMET02597 | ||
| 0.184 | 0.049 | 0.184 | Arachidonic acid antagonist | 0.184 0.049 DBMET02594 0.184 0.049 DBMET02598 0.184 0.049 DBMET02595 0.184 0.049 DBMET02596 0.184 0.049 DBMET02597 | ||
| 0.153 | 0.019 | 0.153 | Phosphodiesterase 4D inhibitor | 0.153 0.019 DBMET02594 0.153 0.019 DBMET02598 0.153 0.019 DBMET02595 0.153 0.019 DBMET02596 0.153 0.019 DBMET02597 | ||
| 0.149 | 0.018 | 0.149 | NADH dehydrogenase inhibitor | 0.149 0.018 DBMET02594 0.149 0.018 DBMET02598 0.149 0.018 DBMET02595 0.149 0.018 DBMET02596 0.149 0.018 DBMET02597 | ||
| 0.141 | 0.011 | 0.141 | Aldose reductase inhibitor | 0.141 0.011 DBMET02594 0.141 0.011 DBMET02598 0.141 0.011 DBMET02595 0.141 0.011 DBMET02596 0.141 0.011 DBMET02597 | ||
| 0.146 | 0.017 | 0.146 | Carbonic anhydrase inhibitor | 0.146 0.017 DBMET02594 0.146 0.017 DBMET02598 0.146 0.017 DBMET02595 0.146 0.017 DBMET02596 0.146 0.017 DBMET02597 | ||
| 0.209 | 0.087 | 0.209 | RNA-directed DNA polymerase inhibitor | 0.209 0.087 DBMET02594 0.209 0.087 DBMET02598 0.209 0.087 DBMET02595 0.209 0.087 DBMET02596 0.209 0.087 DBMET02597 | ||
| 0.149 | 0.027 | 0.149 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.149 0.027 DBMET02594 0.149 0.027 DBMET02598 0.149 0.027 DBMET02595 0.149 0.027 DBMET02596 0.149 0.027 DBMET02597 | ||
| 0.133 | 0.02 | 0.133 | Adrenaline agonist | 0.133 0.02 DBMET02594 0.133 0.02 DBMET02598 0.133 0.02 DBMET02595 0.133 0.02 DBMET02596 0.133 0.02 DBMET02597 | ||
| 0.121 | 0.009 | 0.121 | Caspase 9 inhibitor | 0.121 0.009 DBMET02594 0.121 0.009 DBMET02598 0.121 0.009 DBMET02595 0.121 0.009 DBMET02596 0.121 0.009 DBMET02597 | ||
| 0.118 | 0.007 | 0.118 | H+/K+-transporting ATPase inhibitor | 0.118 0.007 DBMET02594 0.118 0.007 DBMET02598 0.118 0.007 DBMET02595 0.118 0.007 DBMET02596 0.118 0.007 DBMET02597 | ||
| 0.144 | 0.034 | 0.144 | GABA C receptor antagonist | 0.144 0.034 DBMET02594 0.144 0.034 DBMET02598 0.144 0.034 DBMET02595 0.144 0.034 DBMET02596 0.144 0.034 DBMET02597 | ||
| 0.119 | 0.013 | 0.119 | Acyl-CoA dehydrogenase inhibitor | 0.119 0.013 DBMET02594 0.119 0.013 DBMET02598 0.119 0.013 DBMET02595 0.119 0.013 DBMET02596 0.119 0.013 DBMET02597 | ||
| 0.119 | 0.014 | 0.119 | Biliverdin reductase inhibitor | 0.119 0.014 DBMET02594 0.119 0.014 DBMET02598 0.119 0.014 DBMET02595 0.119 0.014 DBMET02596 0.119 0.014 DBMET02597 | ||
| 0.103 | 0.006 | 0.103 | Carbonic anhydrase IV inhibitor | 0.103 0.006 DBMET02594 0.103 0.006 DBMET02598 0.103 0.006 DBMET02595 0.103 0.006 DBMET02596 0.103 0.006 DBMET02597 | ||
| 0.105 | 0.013 | 0.105 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.105 0.013 DBMET02594 0.105 0.013 DBMET02598 0.105 0.013 DBMET02595 0.105 0.013 DBMET02596 0.105 0.013 DBMET02597 | ||
| 0.093 | 0.006 | 0.093 | Glucose-6-phosphate isomerase inhibitor | 0.093 0.006 DBMET02594 0.093 0.006 DBMET02598 0.093 0.006 DBMET02595 0.093 0.006 DBMET02596 0.093 0.006 DBMET02597 | ||
| 0.111 | 0.024 | 0.111 | Glutamate decarboxylase inhibitor | 0.111 0.024 DBMET02594 0.111 0.024 DBMET02598 0.111 0.024 DBMET02595 0.111 0.024 DBMET02596 0.111 0.024 DBMET02597 | ||
| 0.131 | 0.046 | 0.131 | Aminopeptidase B inhibitor | 0.131 0.046 DBMET02594 0.131 0.046 DBMET02598 0.131 0.046 DBMET02595 0.131 0.046 DBMET02596 0.131 0.046 DBMET02597 | ||
| 0.11 | 0.026 | 0.11 | Glutamate dehydrogenase inhibitor | 0.11 0.026 DBMET02594 0.11 0.026 DBMET02598 0.11 0.026 DBMET02595 0.11 0.026 DBMET02596 0.11 0.026 DBMET02597 | ||
| 0.179 | 0.095 | 0.179 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.179 0.095 DBMET02594 0.179 0.095 DBMET02598 0.179 0.095 DBMET02595 0.179 0.095 DBMET02596 0.179 0.095 DBMET02597 | ||
| 0.118 | 0.037 | 0.118 | MAP kinase kinase 1 inhibitor | 0.118 0.037 DBMET02594 0.118 0.037 DBMET02598 0.118 0.037 DBMET02595 0.118 0.037 DBMET02596 0.118 0.037 DBMET02597 | ||
| 0.129 | 0.048 | 0.129 | Ferrochelatase inhibitor | 0.129 0.048 DBMET02594 0.129 0.048 DBMET02598 0.129 0.048 DBMET02595 0.129 0.048 DBMET02596 0.129 0.048 DBMET02597 | ||
| 0.088 | 0.007 | 0.088 | Renin inhibitor | 0.088 0.007 DBMET02594 0.088 0.007 DBMET02598 0.088 0.007 DBMET02595 0.088 0.007 DBMET02596 0.088 0.007 DBMET02597 | ||
| 0.152 | 0.071 | 0.152 | GABA C receptor rho-2 antagonist | 0.152 0.071 DBMET02594 0.152 0.071 DBMET02598 0.152 0.071 DBMET02595 0.152 0.071 DBMET02596 0.152 0.071 DBMET02597 | ||
| 0.12 | 0.04 | 0.12 | GABA C receptor rho-1 antagonist | 0.12 0.04 DBMET02594 0.12 0.04 DBMET02598 0.12 0.04 DBMET02595 0.12 0.04 DBMET02596 0.12 0.04 DBMET02597 | ||
| 0.141 | 0.061 | 0.141 | Acetylcholinesterase inhibitor | 0.141 0.061 DBMET02594 0.141 0.061 DBMET02598 0.141 0.061 DBMET02595 0.141 0.061 DBMET02596 0.141 0.061 DBMET02597 | ||
| 0.084 | 0.007 | 0.084 | Potassium channel (Inward rectifier) activator | 0.084 0.007 DBMET02594 0.084 0.007 DBMET02598 0.084 0.007 DBMET02595 0.084 0.007 DBMET02596 0.084 0.007 DBMET02597 | ||
| 0.082 | 0.006 | 0.082 | Potassium channel (ATP-sensitive) activator | 0.082 0.006 DBMET02594 0.082 0.006 DBMET02598 0.082 0.006 DBMET02595 0.082 0.006 DBMET02596 0.082 0.006 DBMET02597 | ||
| 0.112 | 0.038 | 0.112 | Potassium channel activator | 0.112 0.038 DBMET02594 0.112 0.038 DBMET02598 0.112 0.038 DBMET02595 0.112 0.038 DBMET02596 0.112 0.038 DBMET02597 | ||
| 0.094 | 0.02 | 0.094 | Carbonic anhydrase II inhibitor | 0.094 0.02 DBMET02594 0.094 0.02 DBMET02598 0.094 0.02 DBMET02595 0.094 0.02 DBMET02596 0.094 0.02 DBMET02597 | ||
| 0.125 | 0.051 | 0.125 | Calcium channel (voltage-sensitive) blocker | 0.125 0.051 DBMET02594 0.125 0.051 DBMET02598 0.125 0.051 DBMET02595 0.125 0.051 DBMET02596 0.125 0.051 DBMET02597 | ||
| 0.102 | 0.03 | 0.102 | Rho-associated kinase II inhibitor | 0.102 0.03 DBMET02594 0.102 0.03 DBMET02598 0.102 0.03 DBMET02595 0.102 0.03 DBMET02596 0.102 0.03 DBMET02597 | ||
| 0.118 | 0.047 | 0.118 | DOPA decarboxylase inhibitor | 0.118 0.047 DBMET02594 0.118 0.047 DBMET02598 0.118 0.047 DBMET02595 0.118 0.047 DBMET02596 0.118 0.047 DBMET02597 | ||
| 0.115 | 0.045 | 0.115 | Creatine kinase inhibitor | 0.115 0.045 DBMET02594 0.115 0.045 DBMET02598 0.115 0.045 DBMET02595 0.115 0.045 DBMET02596 0.115 0.045 DBMET02597 | ||
| 0.143 | 0.075 | 0.143 | Adenylate cyclase stimulant | 0.143 0.075 DBMET02594 0.143 0.075 DBMET02598 0.143 0.075 DBMET02595 0.143 0.075 DBMET02596 0.143 0.075 DBMET02597 | ||
| 0.089 | 0.021 | 0.089 | Carbonic anhydrase I inhibitor | 0.089 0.021 DBMET02594 0.089 0.021 DBMET02598 0.089 0.021 DBMET02595 0.089 0.021 DBMET02596 0.089 0.021 DBMET02597 | ||
| 0.099 | 0.032 | 0.099 | Histidine decarboxylase inhibitor | 0.099 0.032 DBMET02594 0.099 0.032 DBMET02598 0.099 0.032 DBMET02595 0.099 0.032 DBMET02596 0.099 0.032 DBMET02597 | ||
| 0.221 | 0.156 | 0.221 | Apoptosis antagonist | 0.221 0.156 DBMET02594 0.221 0.156 DBMET02598 0.221 0.156 DBMET02595 0.221 0.156 DBMET02596 0.221 0.156 DBMET02597 | ||
| 0.077 | 0.015 | 0.077 | Aconitate hydratase inhibitor | 0.077 0.015 DBMET02594 0.077 0.015 DBMET02598 0.077 0.015 DBMET02595 0.077 0.015 DBMET02596 0.077 0.015 DBMET02597 | ||
| 0.091 | 0.032 | 0.091 | Alpha adrenoreceptor agonist | 0.091 0.032 DBMET02594 0.091 0.032 DBMET02598 0.091 0.032 DBMET02595 0.091 0.032 DBMET02596 0.091 0.032 DBMET02597 | ||
| 0.109 | 0.051 | 0.109 | Anabolic | 0.109 0.051 DBMET02594 0.109 0.051 DBMET02598 0.109 0.051 DBMET02595 0.109 0.051 DBMET02596 0.109 0.051 DBMET02597 | ||
| 0.091 | 0.033 | 0.091 | Aminopeptidase I inhibitor | 0.091 0.033 DBMET02594 0.091 0.033 DBMET02598 0.091 0.033 DBMET02595 0.091 0.033 DBMET02596 0.091 0.033 DBMET02597 | ||
| 0.188 | 0.131 | 0.188 | Superoxide dismutase inhibitor | 0.188 0.131 DBMET02594 0.188 0.131 DBMET02598 0.188 0.131 DBMET02595 0.188 0.131 DBMET02596 0.188 0.131 DBMET02597 | ||
| 0.071 | 0.014 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 DBMET02594 0.071 0.014 DBMET02598 0.071 0.014 DBMET02595 0.071 0.014 DBMET02596 0.071 0.014 DBMET02597 | ||
| 0.094 | 0.037 | 0.094 | Na+ K+ transporting ATPase inhibitor | 0.094 0.037 DBMET02594 0.094 0.037 DBMET02598 0.094 0.037 DBMET02595 0.094 0.037 DBMET02596 0.094 0.037 DBMET02597 | ||
| 0.164 | 0.109 | 0.164 | MAP kinase kinase 2 inhibitor | 0.164 0.109 DBMET02594 0.164 0.109 DBMET02598 0.164 0.109 DBMET02595 0.164 0.109 DBMET02596 0.164 0.109 DBMET02597 | ||
| 0.079 | 0.025 | 0.079 | Alpha 2 adrenoreceptor agonist | 0.079 0.025 DBMET02594 0.079 0.025 DBMET02598 0.079 0.025 DBMET02595 0.079 0.025 DBMET02596 0.079 0.025 DBMET02597 | ||
| 0.07 | 0.017 | 0.07 | Alpha-mannosidase inhibitor | 0.07 0.017 DBMET02594 0.07 0.017 DBMET02598 0.07 0.017 DBMET02595 0.07 0.017 DBMET02596 0.07 0.017 DBMET02597 | ||
| 0.076 | 0.023 | 0.076 | Phosphodiesterase 4C inhibitor | 0.076 0.023 DBMET02594 0.076 0.023 DBMET02598 0.076 0.023 DBMET02595 0.076 0.023 DBMET02596 0.076 0.023 DBMET02597 | ||
| 0.076 | 0.023 | 0.076 | Phosphodiesterase 1C inhibitor | 0.076 0.023 DBMET02594 0.076 0.023 DBMET02598 0.076 0.023 DBMET02595 0.076 0.023 DBMET02596 0.076 0.023 DBMET02597 | ||
| 0.061 | 0.008 | 0.061 | Angiotensin AT2 receptor antagonist | 0.061 0.008 DBMET02594 0.061 0.008 DBMET02598 0.061 0.008 DBMET02595 0.061 0.008 DBMET02596 0.061 0.008 DBMET02597 | ||
| 0.085 | 0.034 | 0.085 | Phenylalanine 4-hydroxylase inhibitor | 0.085 0.034 DBMET02594 0.085 0.034 DBMET02598 0.085 0.034 DBMET02595 0.085 0.034 DBMET02596 0.085 0.034 DBMET02597 | ||
| 0.077 | 0.027 | 0.077 | Glutamate (mGluR6) antagonist | 0.077 0.027 DBMET02594 0.077 0.027 DBMET02598 0.077 0.027 DBMET02595 0.077 0.027 DBMET02596 0.077 0.027 DBMET02597 | ||
| 0.131 | 0.084 | 0.131 | Mannose-6-phosphate isomerase inhibitor | 0.131 0.084 DBMET02594 0.131 0.084 DBMET02598 0.131 0.084 DBMET02595 0.131 0.084 DBMET02596 0.131 0.084 DBMET02597 | ||
| 0.087 | 0.041 | 0.087 | Keratolytic | 0.087 0.041 DBMET02594 0.087 0.041 DBMET02598 0.087 0.041 DBMET02595 0.087 0.041 DBMET02596 0.087 0.041 DBMET02597 | ||
| 0.07 | 0.026 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.07 0.026 DBMET02594 0.07 0.026 DBMET02598 0.07 0.026 DBMET02595 0.07 0.026 DBMET02596 0.07 0.026 DBMET02597 | ||
| 0.069 | 0.025 | 0.069 | Phosphodiesterase 1A inhibitor | 0.069 0.025 DBMET02594 0.069 0.025 DBMET02598 0.069 0.025 DBMET02595 0.069 0.025 DBMET02596 0.069 0.025 DBMET02597 | ||
| 0.061 | 0.016 | 0.061 | Mannosidase inhibitor | 0.061 0.016 DBMET02594 0.061 0.016 DBMET02598 0.061 0.016 DBMET02595 0.061 0.016 DBMET02596 0.061 0.016 DBMET02597 | ||
| 0.093 | 0.052 | 0.093 | Ornithine decarboxylase inhibitor | 0.093 0.052 DBMET02594 0.093 0.052 DBMET02598 0.093 0.052 DBMET02595 0.093 0.052 DBMET02596 0.093 0.052 DBMET02597 | ||
| 0.125 | 0.085 | 0.125 | Cytokine production inhibitor | 0.125 0.085 DBMET02594 0.125 0.085 DBMET02598 0.125 0.085 DBMET02595 0.125 0.085 DBMET02596 0.125 0.085 DBMET02597 | ||
| 0.148 | 0.11 | 0.148 | Phospholipase C inhibitor | 0.148 0.11 DBMET02594 0.148 0.11 DBMET02598 0.148 0.11 DBMET02595 0.148 0.11 DBMET02596 0.148 0.11 DBMET02597 | ||
| 0.074 | 0.036 | 0.074 | Exportin-1 inhibitor | 0.074 0.036 DBMET02594 0.074 0.036 DBMET02598 0.074 0.036 DBMET02595 0.074 0.036 DBMET02596 0.074 0.036 DBMET02597 | ||
| 0.136 | 0.099 | 0.136 | Interferon gamma antagonist | 0.136 0.099 DBMET02594 0.136 0.099 DBMET02598 0.136 0.099 DBMET02595 0.136 0.099 DBMET02596 0.136 0.099 DBMET02597 | ||
| 0.107 | 0.069 | 0.107 | Cystathionine beta-synthase inhibitor | 0.107 0.069 DBMET02594 0.107 0.069 DBMET02598 0.107 0.069 DBMET02595 0.107 0.069 DBMET02596 0.107 0.069 DBMET02597 | ||
| 0.046 | 0.009 | 0.046 | Angiotensin II receptor antagonist | 0.046 0.009 DBMET02594 0.046 0.009 DBMET02598 0.046 0.009 DBMET02595 0.046 0.009 DBMET02596 0.046 0.009 DBMET02597 | ||
| 0.098 | 0.062 | 0.098 | Xanthine oxidase inhibitor | 0.098 0.062 DBMET02594 0.098 0.062 DBMET02598 0.098 0.062 DBMET02595 0.098 0.062 DBMET02596 0.098 0.062 DBMET02597 | ||
| 0.049 | 0.014 | 0.049 | Fumarate hydratase inhibitor | 0.049 0.014 DBMET02594 0.049 0.014 DBMET02598 0.049 0.014 DBMET02595 0.049 0.014 DBMET02596 0.049 0.014 DBMET02597 | ||
| 0.077 | 0.042 | 0.077 | Glycine receptor agonist | 0.077 0.042 DBMET02594 0.077 0.042 DBMET02598 0.077 0.042 DBMET02595 0.077 0.042 DBMET02596 0.077 0.042 DBMET02597 | ||
| 0.081 | 0.047 | 0.081 | Catalase inhibitor | 0.081 0.047 DBMET02594 0.081 0.047 DBMET02598 0.081 0.047 DBMET02595 0.081 0.047 DBMET02596 0.081 0.047 DBMET02597 | ||
| 0.097 | 0.067 | 0.097 | Bronchodilator | 0.097 0.067 DBMET02594 0.097 0.067 DBMET02598 0.097 0.067 DBMET02595 0.097 0.067 DBMET02596 0.097 0.067 DBMET02597 | ||
| 0.06 | 0.03 | 0.06 | Angiotensin-converting enzyme inhibitor | 0.06 0.03 DBMET02594 0.06 0.03 DBMET02598 0.06 0.03 DBMET02595 0.06 0.03 DBMET02596 0.06 0.03 DBMET02597 | ||
| 0.077 | 0.047 | 0.077 | Vanilloid 4 agonist | 0.077 0.047 DBMET02594 0.077 0.047 DBMET02598 0.077 0.047 DBMET02595 0.077 0.047 DBMET02596 0.077 0.047 DBMET02597 | ||
| 0.048 | 0.02 | 0.048 | Angiotensin AT1 receptor antagonist | 0.048 0.02 DBMET02594 0.048 0.02 DBMET02598 0.048 0.02 DBMET02595 0.048 0.02 DBMET02596 0.048 0.02 DBMET02597 | ||
| 0.037 | 0.009 | 0.037 | Sodium/glucose cotransporter 2 inhibitor | 0.037 0.009 DBMET02594 0.037 0.009 DBMET02598 0.037 0.009 DBMET02595 0.037 0.009 DBMET02596 0.037 0.009 DBMET02597 | ||
| 0.062 | 0.035 | 0.062 | Argininosuccinate synthase inhibitor | 0.062 0.035 DBMET02594 0.062 0.035 DBMET02598 0.062 0.035 DBMET02595 0.062 0.035 DBMET02596 0.062 0.035 DBMET02597 | ||
| 0.094 | 0.067 | 0.094 | Sphingomyelinase inhibitor | 0.094 0.067 DBMET02594 0.094 0.067 DBMET02598 0.094 0.067 DBMET02595 0.094 0.067 DBMET02596 0.094 0.067 DBMET02597 | ||
| 0.093 | 0.068 | 0.093 | Electrolyte absorption antagonist | 0.093 0.068 DBMET02594 0.093 0.068 DBMET02598 0.093 0.068 DBMET02595 0.093 0.068 DBMET02596 0.093 0.068 DBMET02597 | ||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase VB inhibitor | 0.06 0.035 DBMET02594 0.06 0.035 DBMET02598 0.06 0.035 DBMET02595 0.06 0.035 DBMET02596 0.06 0.035 DBMET02597 | ||
| 0.037 | 0.013 | 0.037 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.037 0.013 DBMET02594 0.037 0.013 DBMET02598 0.037 0.013 DBMET02595 0.037 0.013 DBMET02596 0.037 0.013 DBMET02597 | ||
| 0.061 | 0.04 | 0.061 | Phosphodiesterase 1B inhibitor | 0.061 0.04 DBMET02594 0.061 0.04 DBMET02598 0.061 0.04 DBMET02595 0.061 0.04 DBMET02596 0.061 0.04 DBMET02597 | ||
| 0.054 | 0.033 | 0.054 | Phosphodiesterase 4A inhibitor | 0.054 0.033 DBMET02594 0.054 0.033 DBMET02598 0.054 0.033 DBMET02595 0.054 0.033 DBMET02596 0.054 0.033 DBMET02597 | ||
| 0.086 | 0.065 | 0.086 | Phosphodiesterase I inhibitor | 0.086 0.065 DBMET02594 0.086 0.065 DBMET02598 0.086 0.065 DBMET02595 0.086 0.065 DBMET02596 0.086 0.065 DBMET02597 | ||
| 0.03 | 0.011 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 DBMET02594 0.03 0.011 DBMET02598 0.03 0.011 DBMET02595 0.03 0.011 DBMET02596 0.03 0.011 DBMET02597 | ||
| 0.084 | 0.065 | 0.084 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.065 DBMET02594 0.084 0.065 DBMET02598 0.084 0.065 DBMET02595 0.084 0.065 DBMET02596 0.084 0.065 DBMET02597 | ||
| 0.109 | 0.091 | 0.109 | Cathepsin H inhibitor | 0.109 0.091 DBMET02594 0.109 0.091 DBMET02598 0.109 0.091 DBMET02595 0.109 0.091 DBMET02596 0.109 0.091 DBMET02597 | ||
| 0.122 | 0.105 | 0.122 | Cholinergic | 0.122 0.105 DBMET02594 0.122 0.105 DBMET02598 0.122 0.105 DBMET02595 0.122 0.105 DBMET02596 0.122 0.105 DBMET02597 | ||
| 0.072 | 0.055 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.055 DBMET02594 0.072 0.055 DBMET02598 0.072 0.055 DBMET02595 0.072 0.055 DBMET02596 0.072 0.055 DBMET02597 | ||
| 0.144 | 0.127 | 0.144 | P-glycoprotein inhibitor | 0.144 0.127 DBMET02594 0.144 0.127 DBMET02598 0.144 0.127 DBMET02595 0.144 0.127 DBMET02596 0.144 0.127 DBMET02597 | ||
| 0.042 | 0.026 | 0.042 | Kainate receptor agonist | 0.042 0.026 DBMET02594 0.042 0.026 DBMET02598 0.042 0.026 DBMET02595 0.042 0.026 DBMET02596 0.042 0.026 DBMET02597 | ||
| 0.039 | 0.024 | 0.039 | Glutamate (mGluR8) agonist | 0.039 0.024 DBMET02594 0.039 0.024 DBMET02598 0.039 0.024 DBMET02595 0.039 0.024 DBMET02596 0.039 0.024 DBMET02597 | ||
| 0.034 | 0.019 | 0.034 | Histone deacetylase 10 inhibitor | 0.034 0.019 DBMET02594 0.034 0.019 DBMET02598 0.034 0.019 DBMET02595 0.034 0.019 DBMET02596 0.034 0.019 DBMET02597 | ||
| 0.073 | 0.058 | 0.073 | GABA B receptor agonist | 0.073 0.058 DBMET02594 0.073 0.058 DBMET02598 0.073 0.058 DBMET02595 0.073 0.058 DBMET02596 0.073 0.058 DBMET02597 | ||
| 0.07 | 0.056 | 0.07 | Porphobilinogen synthase inhibitor | 0.07 0.056 DBMET02594 0.07 0.056 DBMET02598 0.07 0.056 DBMET02595 0.07 0.056 DBMET02596 0.07 0.056 DBMET02597 | ||
| 0.03 | 0.016 | 0.03 | Purinergic P2Y15 antagonist | 0.03 0.016 DBMET02594 0.03 0.016 DBMET02598 0.03 0.016 DBMET02595 0.03 0.016 DBMET02596 0.03 0.016 DBMET02597 | ||
| 0.03 | 0.017 | 0.03 | Uridine phosphorylase inhibitor | 0.03 0.017 DBMET02594 0.03 0.017 DBMET02598 0.03 0.017 DBMET02595 0.03 0.017 DBMET02596 0.03 0.017 DBMET02597 | ||
| 0.062 | 0.051 | 0.062 | Calcium channel P-type blocker | 0.062 0.051 DBMET02594 0.062 0.051 DBMET02598 0.062 0.051 DBMET02595 0.062 0.051 DBMET02596 0.062 0.051 DBMET02597 | ||
| 0.051 | 0.041 | 0.051 | Thromboxane antagonist | 0.051 0.041 DBMET02594 0.051 0.041 DBMET02598 0.051 0.041 DBMET02595 0.051 0.041 DBMET02596 0.051 0.041 DBMET02597 | ||
| 0.025 | 0.017 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 DBMET02594 0.025 0.017 DBMET02598 0.025 0.017 DBMET02595 0.025 0.017 DBMET02596 0.025 0.017 DBMET02597 | ||
| 0.019 | 0.01 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET02594 0.019 0.01 DBMET02598 0.019 0.01 DBMET02595 0.019 0.01 DBMET02596 0.019 0.01 DBMET02597 | ||
| 0.061 | 0.053 | 0.061 | Beta 3 adrenoreceptor antagonist | 0.061 0.053 DBMET02594 0.061 0.053 DBMET02598 0.061 0.053 DBMET02595 0.061 0.053 DBMET02596 0.061 0.053 DBMET02597 | ||
| 0.098 | 0.091 | 0.098 | Alkylator | 0.098 0.091 DBMET02594 0.098 0.091 DBMET02598 0.098 0.091 DBMET02595 0.098 0.091 DBMET02596 0.098 0.091 DBMET02597 | ||
| 0.015 | 0.008 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 DBMET02594 0.015 0.008 DBMET02598 0.015 0.008 DBMET02595 0.015 0.008 DBMET02596 0.015 0.008 DBMET02597 | ||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase X inhibitor | 0.017 0.011 DBMET02594 0.017 0.011 DBMET02598 0.017 0.011 DBMET02595 0.017 0.011 DBMET02596 0.017 0.011 DBMET02597 | ||
| 0.017 | 0.011 | 0.017 | Carbonic anhydrase VIII inhibitor | 0.017 0.011 DBMET02594 0.017 0.011 DBMET02598 0.017 0.011 DBMET02595 0.017 0.011 DBMET02596 0.017 0.011 DBMET02597 | ||
| 0.078 | 0.074 | 0.078 | Estrogen-related receptor beta agonist | 0.078 0.074 DBMET02594 0.078 0.074 DBMET02598 0.078 0.074 DBMET02595 0.078 0.074 DBMET02596 0.078 0.074 DBMET02597 | ||
| 0.039 | 0.036 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.036 DBMET02594 0.039 0.036 DBMET02598 0.039 0.036 DBMET02595 0.039 0.036 DBMET02596 0.039 0.036 DBMET02597 | ||
| 0.032 | 0.029 | 0.032 | HMG CoA reductase inhibitor | 0.032 0.029 DBMET02594 0.032 0.029 DBMET02598 0.032 0.029 DBMET02595 0.032 0.029 DBMET02596 0.032 0.029 DBMET02597 | ||
| 0.1 | 0.098 | 0.1 | Aldehyde dehydrogenase inhibitor | 0.1 0.098 DBMET02594 0.1 0.098 DBMET02598 0.1 0.098 DBMET02595 0.1 0.098 DBMET02596 0.1 0.098 DBMET02597 | ||
| 0.038 | 0.037 | 0.038 | Guanylate cyclase inhibitor | 0.038 0.037 DBMET02594 0.038 0.037 DBMET02598 0.038 0.037 DBMET02595 0.038 0.037 DBMET02596 0.038 0.037 DBMET02597 | ||
| 0.019 | 0.018 | 0.019 | Corticosteroid-like | 0.019 0.018 DBMET02594 0.019 0.018 DBMET02598 0.019 0.018 DBMET02595 0.019 0.018 DBMET02596 0.019 0.018 DBMET02597 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |